About Us

Capital Area AIDS Prevention Effort (CAAPE) is a volunteer group of individuals from the diverse communities affected by HIV/AIDS. CAAPE is organized to assist and advise HIV vaccine trials that are being conducted in the metropolitan Washington, DC area. 

Mission: Capital Area AIDS Prevention Effort is the local voice for HIV Prevention Research. 

CAAPE is one of many volunteer Community Advisory Boards across the United States and around the world. CAAPE believes that community participation contributes to better science and better health outcomes for affected communities. Part of CAAPE's role is to monitor the research strategies and approaches so that values and cultural and ethnic differences among vaccine trial participants are respected.

To fulfill its mission, CAAPE:

• engages in education, outreach and advocacy activities in our community
• assists in the planning, development, and implementation of HIV Vaccine Trials Network research
• assesses community impact and ensure community concerns are considered
• serves as a voice for the community and study participants.

CAAPE meetings are generally held monthly and hosted at the DC Center. For upcoming meetings and events, please visit our Events Calendar.

Become a CAAPE volunteer

CAAPE members include community activists and/or professionals associated with HIV/AlDS prevention and services delivery. Some of members are trial participants. Many have considerable scientific sophistication or relevant professional training, while others have no medical or scientific background but have a strong interest in HIV prevention. New volunteers are encouraged to contact the DC Center or to email info@aidsvaccine.org regarding upcoming CAAPE meetings and outreach events.

VACCINE RESEARCH CENTER Capital Area AIDS Prevention Effort serves as the Community Advisory Board for the Vaccine Research Center.

VACCINE RESEARCH CENTER Capital Area AIDS Prevention Effort is the Community Advisory Board for the Rockville Vaccine Assessment Clinic. Are you a man between 18 and 50 years old and HIV negative? Learn more about an HIV vaccine study taking place in the District of Columbia and turn hope into action.